Comparison of Hemodynamic Responses Associated with Tracheal Intubation Under Various Induction Doses of Remifentanil and Propofol

Abstract

.Background: The optimal dose of propofol and remifentanil induction to minimize the cardiovascular response associated with tracheal intubation may exist. We investigated the cardiovascular response associated with tracheal intubation when various continuous induction doses of remifentanil in combination with propofol were used. Methods: Seventy- five patients were randomly allocated into 1 of 3 groups: the R-0.4 P-1 group (remifentanil 0.4 μg/kg/min and propofol 1 mg/kg); the R-0.5 P-1 group (remifentanil 0.5 μg/kg/min and propofol 1 mg/kg); and the R-0.4 P-2 group (remifentanil 0.4 μg/kg/min and propofol 2 mg/kg). One minute after remifentanil infusion commenced, a bolus of propofol was injected. Rocuronium 1 mg/kg was administered 1 min after propofol injection following loss of consciousness. Controlled ventilation was then performed for 2 min, and the trachea was intubated 4 min after the start of the remifentanil infusion. The infusion rate of remifentanil was decreased to 0.1 μg/kg/min after intubation. Blood pressure (BP) and heart rate (HR) were measured during this period until 5 min after tracheal intubation. Results: The changes in BP response due to tracheal intubation in the R-0.4 P-1 group were greater than those in the other 2 groups, whereas the HR responses to tracheal intubation were similar among the 3 groups. Conclusion: The combination of remifentanil 0.4 μg/kg/min and propofol 1 mg/kg led to an exaggerated cardiovascular response to tracheal intubation compared with the other combination groups.

Share and Cite:

T. Goyagi and M. Yoshimoto, "Comparison of Hemodynamic Responses Associated with Tracheal Intubation Under Various Induction Doses of Remifentanil and Propofol," Open Journal of Anesthesiology, Vol. 2 No. 4, 2012, pp. 154-160. doi: 10.4236/ojanes.2012.24035.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] A. L. Kovac, “Controlling the Hemodynamic Response to Laryngoscopy and Endotracheal Intubation,” Journal of Clinical Anesthesia, Vol. 8, No. 1, 1996, pp. 63-79. doi:10.1016/0952-8180(95)00147-6
[2] N. Bruder, D. Ortega and C. Granthil, “Consequences and Prevention Methods of Hemodynamic Changes during Laryngoscopy and Intratracheal Intubation,” Annales Fran?aises Danesthèsie et de Reanimation, Vol. 11, No. 1, 1992, pp. 57-71. doi:10.1016/S0750-7658(05)80321-1
[3] J. Horak and S. Weiss, “Emergent Management of the Airway. New Pharmacology and the Control of Comorbidities in Cardiac Disease, Ischemia, and Valvular Heart Disease,” Critical Care Clinics, Vol. 16, No. 3, 2000, pp. 411-427. doi:10.1016/S0749-0704(05)70120-2
[4] A. Albertin, A. Casati, L. Federica, V. Roberto, V. Travaglini, P. Bergonzi and G. Torri, “The Effect-Site Concentration of Remifentanil Blunting Cardiovascular Responses to Tracheal Intubation and Skin Incision during Bispectral Index-Guided Propofol Anesthesia,” Anesthesia and Analgesia, Vol. 101, No. 1, 2005, pp. 125-130. doi:10.1213/01.ANE.0000153012.35120.FE
[5] M. J. Mertens, E. Olofsen, F. H. Engbers, A. G. Burm, J. G. Bovill and J. Vuyk, “Propofol Reduces Perioperative Remifentanil Requirements in a Synergistic Manner: Response Surface Modeling of Perioperative Remifentanil-Propofol Interactions,” Anesthesiology, Vol. 99, No. 3, 2003, pp. 347-359. doi:10.1097/00000542-200308000-00016
[6] T. W. Bouillon, J. Bruhn, L. Radulescu, C. Andresen, T. J. Shafer, C. Cohane and S. L. Shafer, “Pharmacodynamic Interaction between Propofol and Remifentanil Regarding Hypnosis, Tolerance of Laryngoscopy, Bispectral Index, and Electroencephalographic Approximate Entropy,” Anesthesiology, Vol. 100, No. 6, 2004, pp. 1353-1372. doi:10.1097/00000542-200406000-00006
[7] S. E. Kern, G. Xie, J. L. White and T. D. Egan, “A Response Surface Analysis of Propofol-Remifentanil Pharmacodynamic Interaction in Volunteers,” Anesthesiology, Vol. 100, No. 6, 2004, pp. 1373-1381. doi:10.1097/00000542-200406000-00007
[8] Q. Y. Yang, F. S. Xue, X. Liao, H. P. Liu, M. P. Luo, Y. C. Xu, Y. Liu and Y.M. Zhang, “Comparison of Bolus Remifentanil versus Bolus Fentanyl for Blunting Cardiovascular Intubation Responses in Children: A Randomized, Double-Blind Study,” Chinese Medical Journal, Vol. 122, No. 1, 2009, pp. 44-50.
[9] X. Liao, Q. Y. Yang, F. S. Xue, M. P. Luo, Y. C. Xu, Y. Liu and Y.M. Zhang, “Bolus Dose Remifentanil and Sufentanil Blunting Cardiovascular Intubation Responses in Children: A Randomized, Double-Blind Comparison,” European Journal of Anaesthesiology, Vol. 26, No. 1, 2009, pp. 73-80. doi:10.1097/EJA.0b013e32831a6b2f
[10] S. Mohammadreza and H. Azim, “Tracheal Intubation without Muscle Relaxants: A Randomized Study of Remifentanil or Alfentanil in Combination with Thiopental,” Annals of Saudi Medicine, Vol. 28, No. 2, 2008, pp. 89-95. doi:10.4103/0256-4947.51746
[11] F. S. Xue, Y. C. Xu, Y. Liu, Q. Y. Yang, X. Liao, K. P. Liu, C. W. Li and H.T. Sun, “Different Small-Dose Remifentanil Blunting the Cardiovascular Response to Laryngoscopy and Intubation in Children: A Randomized Double-Blind Comparison,” European Journal of Anaesthesiology, Vol. 25, No. 2, 2008, pp. 106-112. doi:10.1017/S026502150700261X
[12] U. M. Klemola, S. Mennander and L. Saarnivaara, “Tracheal Intubation without the Use of Muscle Relaxants: Remifentanil or Alfentanil in Combination with Propofol,” Acta Anaesthesiologica Scandinavica, Vol. 44, No. 4, 2000, pp. 465-469. doi:10.1034/j.1399-6576.2000.440419.x
[13] B. Y. Park, C. W. Jeong, E. A. Jang, S. J. Kim, S. T. Jeong, M. H. Shin, J. Lee and K.Y. Yoo, “Dose-Related Attenuation of Cardiovascular Responses to Tracheal Intubation by Intravenous Remifentanil Bolus in Severe Pre-Eclamptic Patients Undergoing Caesarean Delivery,” British Journal of Anaesthesia, Vol. 106, No. 1, 2011, pp. 82-87. doi:10.1093/bja/aeq275
[14] A. M. Maguire, N. Kumar, J. L. Parker, D. J. Rowbotham and J. P. Thompson, “Comparison of Effects of Remifentanil and Alfentanil on Cardiovascular Response to Tracheal Intubation in Hypertensive Patients,” British Journal of Anaesthesia, Vol. 86, No. 1, 2001, pp. 90-93. doi:10.1093/bja/86.1.90
[15] A. S. Habib, J. L. Parker, A. M. Maguire, D. J. Rowbotham and J. P. Thompson, “Effects of Remifentanil and Alfentanil on the Cardiovascular Responses to Induction of Anaesthesia and Tracheal Intubation in the Elderly,” British Journal of Anaesthesia, Vol. 88, No. 3, 2002, pp. 430-433. doi:10.1093/bja/88.3.430
[16] Z. Salihoglu, S. Demiroluk and Y. Kose, “Comparison of Effects of Remifentanil, Alfentanil and Fentanyl on Cardiovascular Responses to Tracheal Intubation in Morbidly Obese Patients,” European Journal of Anaesthesiology, Vol. 19, No. 2, 2002, pp. 125-128.
[17] W. Miyake, Y. Oda, Y. Ikeda, K. Tanaka, S. Hagihira, H. Iwaki and A. Asada, “Effect of Remifentanil on Cardiovascular and Bispectral Index Responses Following the Induction of Anesthesia with Midazolam and Subsequent Tracheal Intubation,” Journal of Anesthesia, Vol. 24, No. 2, 2010, pp. 161-167. doi:10.1007/s00540-010-0895-4
[18] A. P. Hall, J. P. Thompson, N. A. Leslie, A. J. Fox, N. Kumar and D. J. Rowbotham, “Comparison of Different Doses of Remifentanil on the Cardiovascular Response to Laryngoscopy and Tracheal Intubation,” British Journal of Anaesthesia, Vol. 84, No. 1, 2000, pp. 100-102. doi:10.1093/oxfordjournals.bja.a013362
[19] T. P. Chaves, J. M. Gomes, F. E. Pereira, S. L. Cavalcante, I. M. Leit?o, H. S. Monte and R. D. Escalant, “Hemodynamic and Metabolic Evaluation of Dexmedetomidine and Remifentanil Continuous Infusion in Videolaparoscopic Cholecystectomy: Comparative Study,” Revista Brasileira de Anestesiologia, Vol. 53, No. 4, 2003, pp. 419-430. doi:10.1590/S0034-70942003000400001
[20] R. K. Stoelting, “Circulatory Changes during Direct Laryngoscopy and Tracheal Intubation: Influence of Duration of Laryngoscopy with or without Prior Lidocaine,” Anesthesiology, Vol. 47, No. 4, 1977, pp. 381-384. doi:10.1097/00000542-197710000-00012
[21] C. Prys-Roberts, L. T. Greene, R. Meloche and P. Fo?x, “Studies of Anaesthesia in Relation to Hypertension. II. Haemodynamic Consequences of Induction and Endotracheal Intubation,” British Journal of Anaesthesia, Vol. 43, No. 6, 1971, pp. 531-547. doi:10.1093/bja/43.6.531
[22] K. Y. Yoo, C. W. Jeong, W. M. Kim, H. K. Lee, S. Jeong, S. J. Kim, H. B. Bae, D. Y. Lim and S. S. Chung, “Cardiovascular and Arousal Responses to Single-Lumen Endotracheal and Double-Lumen Endobronchial Intubation in the Normotensive and Hypertensive Elderly,” Korean Journal of Anesthesiology, Vol. 60, No. 2, 2011, pp. 9097. doi:10.4097/kjae.2011.60.2.90
[23] S. Kihara, J. Brimacombe, Y. Yaguchi, S. Watanabe, N. Taguchi and T. Komatsuzaki, “Hemodynamic Responses among Three Tracheal Intubation Devices in Normotensive and Hypertensive Patients,” Anesthesia and Analgesia, Vol. 3, No. 3, 2003, pp. 890-895. doi:10.1213/01.ANE.0000048706.15720.C9
[24] L. M. Van Bortel and J. J. Spek, “Influence of Aging on Arterial Compliance,” Journal of Human Hypertension, Vol. 12, No. 9, 1998, pp. 583-586. doi:10.1038/sj.jhh.1000669

Journals Menu
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.